Reticulate pigmentation due to 5-fluorouracil.
Allen
B J
BJ
Parker
D
D
Wright
A L
AL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary; D004890:Erythema / Q000139:chemically induced; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007414:Intestinal Neoplasms; D008297:Male; D008875:Middle Aged
D001761:Bleomycin; D005472:Fluorouracil